Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

New Hurdle for Orexigen Diet Pill Has Investors Worried
Seeking Alpha
Monday, February 7, 2011 - 7:56am
tags:
Orexigen, obesity, Contrave, FDA
Pfizer will buy Ferrosan consumer health business
Yahoo/AP
Monday, February 7, 2011 - 7:54am
tags:
Pfizer, Ferrosan, M&A
AstraZeneca halts prostrate cancer drug trial
Marketwatch
Monday, February 7, 2011 - 7:52am
tags:
AstraZeneca, prostate cancer, zibotentan
Pfizer Looks to Partners as It Narrows Therapeutic Focus
Seeking Alpha
Monday, February 7, 2011 - 7:51am
tags:
Pfizer, M&A
Sanofi, Genzyme Work Toward Deal
TheStreet.com
Monday, February 7, 2011 - 7:50am
tags:
Sanofi, M&A, Genzyme
"Big Pharma has Created Wealth, While Biotech has Destroyed Wealth"
PRLog
Saturday, February 5, 2011 - 11:51am
tags:
Big Pharma
Pfizer & Takeda enter co-promotion agreements for rheumatoid arthritis products in Japan
pharmabiz
Saturday, February 5, 2011 - 11:47am
tags:
Pfizer, Takeda, Enbrel, tasocitinib, CP-690, 550, rheumatoid arthritis
Sanofi could sweeten bid for Genzyme before next Wednesday: Report
International Business Times
Saturday, February 5, 2011 - 11:45am
tags:
Sanofi, M&A, Genzyme
Perrigo Excels, Lifts Outlook
Yahoo/Zacks
Saturday, February 5, 2011 - 11:10am
tags:
Perrigo Company
Lilly Will Tie Bonuses to Drug Development in Face of Generic Competition
Bloomberg
Saturday, February 5, 2011 - 11:08am
tags:
Eli Lilly
Risperdal Overcharge Trial Looms Over J&J
The Street
Saturday, February 5, 2011 - 11:07am
tags:
JNJ, Risperdal, lawsuits
How to Profit From Health Care: Teva Pharmaceuticals
Seeking Alpha
Saturday, February 5, 2011 - 11:06am
tags:
Teva Pharmaceuticals, investors
Makena Approval Jump-Starts KV Pharmaceutical
Forbes
Saturday, February 5, 2011 - 11:06am
tags:
Makena, KV Pharmaceutical, premature birth
Strategy: Merck vs. Pfizer
Seeking Alpha
Saturday, February 5, 2011 - 11:04am
tags:
Merck, Pfizer, investors
Theravance Poised to Jump
Minyanville
Saturday, February 5, 2011 - 11:01am
tags:
Theravance, GSK, Relovair, COPD
Value Pharma Stocks in Overpriced Market
Seeking Alpha
Saturday, February 5, 2011 - 10:59am
tags:
Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GSK, JNJ, Merck, Novartis, Pfizer, Roche, Sanofi
Vertex loss widens ahead of FDA drug decision
bizjournals.com
Saturday, February 5, 2011 - 10:56am
tags:
Vertex Pharmaceuticals, Telaprevir
Endocyte cuts IPO price expectation
Yahoo/AP
Saturday, February 5, 2011 - 10:55am
tags:
Endocyte
Savient Closes Sale of $230 Million in Convertible Senior Notes
Yahoo/PR NewsWire
Saturday, February 5, 2011 - 10:51am
tags:
Savient
Celgene: Bargain Biotech
Seeking Alpha
Saturday, February 5, 2011 - 10:50am
tags:
Celgene, investors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.